Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Manufacturing (cGMP) deviations

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards.

1,754 FDA drug recalls with this cause, newest first.

This category covers departures from current Good Manufacturing Practice during production. It is FDA's broadest label, used when a facility's own process control failed somewhere along the line even if no single ingredient was proven unsafe on its own. Where the report names a specific consequence - a temperature excursion, a contaminant, a potency problem - we file the recall under that more specific cause instead; what remains here is the genuinely general case.

Class II · Moderate risk

Streptococcinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1137-2022
Class II · Moderate risk

Pyrogenium

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1136-2022
Class II · Moderate risk

Proteus

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1135-2022
Class II · Moderate risk

Pertussinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1134-2022
Class II · Moderate risk

Morbillinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1133-2022
Class II · Moderate risk

Medorrhinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1132-2022
Class II · Moderate risk

Influenzinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1131-2022
Class II · Moderate risk

Diphtherinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1130-2022
Class II · Moderate risk

Colibacillinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1129-2022
Class II · Moderate risk

Anthracinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1125-2022
Class II · Moderate risk

Alcohol Antiseptic 80%

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Ongoing cGMP deviation A.P. Nonweiler D-1142-2022
Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-130-01 D-0793-2022
Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-129-01 D-0792-2022
Class II · Moderate risk

Torco Racing Fuels Hand Sanitizer

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Terminated cGMP deviation Torco Race Fuels D-0786-2022